These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 25827958)
1. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia. Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958 [TBL] [Abstract][Full Text] [Related]
2. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. Xiu MH; Chen DC; Wang D; Zhang K; Dong A; Tang W; Zhang F; Liu LJ; Liu JH; Liu HB; Yang FD; Kosten TR; Zhang XY J Psychiatr Res; 2012 Aug; 46(8):1093-8. PubMed ID: 22647522 [TBL] [Abstract][Full Text] [Related]
3. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology. Xiu MH; Yang GG; Tan YL; Chen DC; Tan SP; Wang ZR; Yang FD; Okusaga O; Soares JC; Zhang XY Schizophr Res; 2014 Jun; 156(1):9-14. PubMed ID: 24766914 [TBL] [Abstract][Full Text] [Related]
4. Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia. Fu YY; Zhang T; Xiu MH; Tang W; Han M; Yun LT; Chen DC; Chen S; Tan SP; Soares JC; Tang WJ; Zhang XY Schizophr Res; 2016 Oct; 176(2-3):196-200. PubMed ID: 27237600 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response. Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Stefanovic V; Arsenijevic N; Lukic ML Schizophr Res; 2013 Jun; 147(1):103-109. PubMed ID: 23602340 [TBL] [Abstract][Full Text] [Related]
6. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721 [TBL] [Abstract][Full Text] [Related]
7. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116 [TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia. Tan Y; Li Y; Tan S; Wang Z; Yang FD; Cao B; Zunta-Soares GB; Soares JC; Zhang XY Schizophr Res; 2015 Dec; 169(1-3):16-21. PubMed ID: 26549630 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591 [TBL] [Abstract][Full Text] [Related]
10. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls. Kubistova A; Horacek J; Novak T Psychiatr Danub; 2012 Sep; 24 Suppl 1():S153-6. PubMed ID: 22945211 [TBL] [Abstract][Full Text] [Related]
11. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Zhang XY; Chen DC; Xiu MH; Wang F; Qi LY; Sun HQ; Chen S; He SC; Wu GY; Haile CN; Kosten TA; Lu L; Kosten TR Schizophr Res; 2009 Sep; 113(2-3):151-7. PubMed ID: 19540723 [TBL] [Abstract][Full Text] [Related]
12. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment. Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695 [TBL] [Abstract][Full Text] [Related]
13. Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone. Azizi E; Zavaran Hosseini A; Soudi S; Noorbala AA Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):262-268. PubMed ID: 31522433 [TBL] [Abstract][Full Text] [Related]
14. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia]. Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770 [TBL] [Abstract][Full Text] [Related]
15. Activation of Th17 cells in drug naïve, first episode schizophrenia. Ding M; Song X; Zhao J; Gao J; Li X; Yang G; Wang X; Harrington A; Fan X; Lv L Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():78-82. PubMed ID: 24447943 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia. Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607 [TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977 [TBL] [Abstract][Full Text] [Related]
18. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]. Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index. Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730 [TBL] [Abstract][Full Text] [Related]
20. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Pirildar S; Gönül AS; Taneli F; Akdeniz F Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]